Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miravirsen in Treatment-Naïve Chronic Hepatitis C
NCT01200420Phase 2Completed
- Sponsor
- Santaris Pharma
- Start
- Sep 2010
- Primary completion
- Dec 2011
- Modality
- Small Interfering RNA (siRNA), Modified DNA Oligonucleotides, Single-strand DNA
- Countries
- 6
01
Overview
A Phase 2 trial of miravirsen in hepatitis C (HCV), sponsored by Santaris Pharma. Started Sep 2010; status: completed.
02
Drugs
miravirsen
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01200420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01200420.